{"id":"W4362640931","doi":"10.1016/j.jclinepi.2023.03.028","title":"Bypassing phase 2 in cancer drug development erodes the risk/benefit balance in phase 3 trials","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Epidemiology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"NOSM University; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Clinical trial; Medicine; Randomized controlled trial; Clinical study design; Balance (ability); Intensive care medicine; Internal medicine; Physical therapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.4947688,0.0008473172,0.03554,0.0005574634,0.0001052329,0.00003403874,0.001775932,0.001678909,0.0003029451],"category_scores_gemma":[0.9522209,0.000447981,0.003829292,0.0009857001,0.0006701688,0.00009095718,0.0003525347,0.007636006,0.00005776819],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000431268,"about_ca_system_score_gemma":0.002323796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006859726,"about_ca_topic_score_gemma":0.0002354906,"domain_scores_codex":[0.74492,0.1768541,0.07432547,0.001406452,0.0009326501,0.00156142],"domain_scores_gemma":[0.08923134,0.8726091,0.0365141,0.0008715662,0.0002958901,0.0004779691],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0006024885,0.0012811,0.0008206827,0.003376961,0.0008843582,0.0001616049,0.00005801061,0.0000196902,3.574678e-8,0.003320369,0.005136895,0.9843378],"study_design_scores_gemma":[0.009065119,0.0003778478,0.0002798135,0.03168319,0.001805178,0.00002996908,0.00002332746,0.0002041627,3.543801e-7,0.5611699,0.3948958,0.0004653961],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009949291,0.9707039,0.0166304,0.001849212,0.007532366,0.001921121,0.0002787081,0.00003541354,0.0000539264],"genre_scores_gemma":[0.000006729234,0.7738873,0.2224258,0.000405486,0.002887671,0.000166368,0.000003563667,0.00009481818,0.0001222254],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9838724,"threshold_uncertainty_score":0.9997972,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.9540781456989651,"score_gpt":0.7867139564248123,"score_spread":0.1673641892741528,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}